Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026)

Tilray Brands' (TLRY) quarterly Cash from Investing Activities came in at -$51.2 million in Q2 2026, down 478.51% YoY from $13.5 million in Q2 2025, and down 276.99% on a QoQ basis from $28.9 million in Q1 2026.

Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 10 years of Cash from Investing Activities data on file, last reported at -$51.2 million in Q2 2026.

  • Quarterly Cash from Investing Activities fell 478.51% year-over-year to -$51.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$55.8 million (down 19.44% YoY) and the FY2026 annual result came in at -$55.8 million, down 19.44% from the prior year.
  • Cash from Investing Activities slipped to -$51.2 million in Q2 2026, from $28.9 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $81.5 million in Q4 2023 to a low of -$271.4 million in Q4 2022.
  • A 5-year average of -$14.7 million and a median of -$3.1 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 3792.69% — and 2026, when it soared 24400.0%.
  • Tracing TLRY's Cash from Investing Activities over 5 years: stood at -$271.4 million in 2022, then surged by 130.03% to $81.5 million in 2023, then tumbled by 113.16% to -$10.7 million in 2024, then tumbled by 440.84% to -$58.0 million in 2025, then grew by 11.77% to -$51.2 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$51.2 million (Q2 2026), $28.9 million (Q1 2026), and -$58.0 million (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -491.00 Mn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -300.00 Mn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn -550.24 Mn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.50 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -51.60 Mn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn -135.40 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn -110.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn -51.18 Mn

Historic Data

Download Data
DateValue
May 31, 2026 -51.18 Mn
May 31, 2026 -51.18 Mn
Feb 28, 2026 28.92 Mn
Feb 28, 2026 28.92 Mn
Nov 30, 2025 -58.01 Mn
Nov 30, 2025 -58.01 Mn
Aug 31, 2025 24.47 Mn
Aug 31, 2025 24.47 Mn
May 31, 2025 13.52 Mn
May 31, 2025 13.52 Mn
Feb 28, 2025 -119,000.00
Feb 28, 2025 -119,000.00
Nov 30, 2024 -10.73 Mn
Nov 30, 2024 -10.73 Mn
Aug 31, 2024 -49.40 Mn
Aug 31, 2024 -49.40 Mn
May 31, 2024 45.06 Mn
May 31, 2024 45.06 Mn
Feb 29, 2024 28.09 Mn
Feb 29, 2024 28.09 Mn